ONCO — Oncopeptides AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Oncopeptides AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	362	345	173	179	82.3
Net Total Accounts Receivable
Net Total Receivables	38	17.3	17.9	13.5	26.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	412	364	203	217	117
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	24.7	20.4	34.6	27.1	17.7
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	439	385	238	244	135
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	225	85.7	44.9	51.4	44.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	229	91	182	190	194
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	211	294	56.8	54.3	-58.9
Total Liabilities & Shareholders' Equity	439	385	238	244	135
Total Common Shares Outstanding